Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 2, 2008, Pages 239-240

  Nunokawa, Ayako ^a   Watanabe, Yuichiro ^a   Kitamura, Hideaki ^a   Kaneko, Naoshi ^a   Arinami, Tadao ^b   Ujike, Hiroshi ^c   Inada, Toshiya ^d   Iwata, Nakao ^e   Kunugi, Hiroshi ^g   Itokawa, Masanari ^h   Ozaki, Norio ^f   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^h TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METABOTROPIC RECEPTOR 3;

AGE DISTRIBUTION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; LETTER; SCHIZOPHRENIA; SEX RATIO;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

EID: 42149166725     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01762.x     Document Type: Letter

References (9)

1. Egan MF, Straub RE, Goldberg TE et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Natl Acad. Sci. USA 2004 101 : 12 04 12 09.
2. Norton N, Williams HJ, Dwyer S et al. No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry 2005 5 : 23.
3. Tochigi M, Suga M, Ohashi J et al. No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population. Schizophr. Res. 2006 88 : 260 264.
4. Nicodemus KK, Kolachana BS, Vakkalanka R et al. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: Influence on risk of schizophrenia. Hum. Genet. 2007 120 : 889 906.
5. Albalushi T, Horiuchi Y, Ishiguro H et al. Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007 Oct 19 [Epub ahead of print].
6. Watanabe Y, Fukui N, Muratake T et al. Association study of a functional promoter polymorphism of the X-box binding protein 1 gene in Japanese patients with schizophrenia. Psychiatry Clin. Neurosci. 2006 60 : 633 635.
7. Fujii Y, Shibata H, Kikuta R et al. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr. Genet. 2003 13 : 71 76.
8. Chen Q, He G, Chen Q et al. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr. Res. 2005 73 : 21 26.
9. Bishop JR, Ellingrod VL, Moline J, Miller D. Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr. Res. 2005 77 : 253 260.